Emergence of hepatitis C virus resistance associated variants in patients failing direct acting antivirals by ultra-deep sequencing

被引：0
|
作者：
Nguyen, T. [1 ,2 ]
Akhavan, S. [3 ]
Caby, F. [4 ]
Bonyhay, L. [5 ]
Larrouy, L. [6 ]
Gervais, A. [7 ]
Lebray, P. [5 ]
Poynard, T. [8 ]
Calmus, Y. [9 ]
Simon, A. [10 ]
Valantin, M. -A. [4 ]
Calvez, V. [1 ,2 ]
Marcelin, A. -G. [1 ,2 ]
Todesco, E. [1 ,2 ]
机构：
[1] Inst Pierre Louis Epidemiol, Paris, France
[2] UPMC Univ Paris 06, Sorbonne Univ, Paris, France
[3] Hop La Pitie Salpetriere, AP HP, Dept Virol, Paris, France
[4] Hop La Pitie Salpetriere, AP HP, Infect Dis Dept, Paris, France
[5] Hop La Pitie Salpetriere, Serv Hepatogastroenterol, Paris, France
[6] Univ Paris Diderot, Hop Bichat, Sorbonne Paris Cite, Lab Virol,AP HP,INSERM,IAME,UMR 1137, Paris, France
[7] Hop Bichat Claude Bernard, AP HP, Serv Malad Infect & Trop, Paris, France
[8] Univ Paris 06, Grp Hosp Pitie Salpetriere, Inst Cardiometab & Nutr ICAN, France Sorbonne Univ,UPMC,AP HP,INSERM,UMR S 938, Paris, France
[9] UPMC Paris VI, Hop Pitie Salpetriere, AP HP, Unite Med Transplantat Hepat,Hepatogastroenterol, Blvd Hop, Paris, France
[10] Hop La Pitie Salpetriere, AP HP, Dept Med Interne & Immunol Clin, Paris, France
来源：
JOURNAL OF HEPATOLOGY | 2018年 / 68卷
关键词：
D O I：
10.1016/S0168-8278(18)30751-7
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
THU-310
引用
收藏
页码：S268 / S268
页数：1
相关论文
共 50 条
  • [31] Direct-acting antivirals for hepatitis C virus-infected patients with hepatocellular carcinoma
    Tajiri, Kazuto
    Ito, Hiroyuki
    Kawai, Kengo
    Kashii, Yoshiro
    Hayashi, Yuka
    Murayama, Aiko
    Minemura, Masami
    Takahara, Terumi
    Shimizu, Yukihiro
    Yasuda, Ichiro
    WORLD JOURNAL OF HEPATOLOGY, 2022, 14 (06) : 1190 - 1199
  • [32] Lipid modification in hepatitis C virus-monoinfected patients treated with direct acting antivirals
    Juanbeltz, R.
    Goni, S.
    Martinez-Echeverria, A.
    Elizalde, I.
    Zozaya, J. M.
    Castilla, J.
    Uriz, J. I.
    Miguel, R. S.
    JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S733 - S733
  • [33] EFFECTIVENESS AND SAFETY OF DIRECT-ACTING ANTIVIRALS IN PSYCHIATRIC HEPATITIS C VIRUS INFECTED PATIENTS
    Margusino-Framinan, Luis
    Bobadilla-Perez, Eva
    Carlos Yanez-Rubal, Juan
    Prieto-Perez, Andrea
    Cid-Silva, Purificacion
    Rodriguez-Sotelo, Alejandro
    Gimenez-Arufe, Victor
    Quiroga-Fernandez, Candela
    Isabel Sanclaudio-Luhia, Ana
    Novo-Ponte, Ana
    Mena-De-Cea, Alvaro
    Martin-Herranz, Isabel
    Castro-Iglesias, Angeles
    HEPATOLOGY, 2019, 70 : 966A - 966A
  • [34] Characteristics of hepatitis C virus resistance in an international cohort after a decade of direct-acting antivirals
    Howe, Anita Y. M.
    Rodrigo, Chaturaka
    Cunningham, Evan B.
    Douglas, Mark W.
    Dietz, Julia
    Grebely, Jason
    Popping, Stephanie
    Sfalcin, Javier Alejandro
    Parczewski, Milosz
    Sarrazin, Christoph
    de Salazar, Adolfo
    Fuentes, Ana
    Sayan, Murat
    Quer, Josep
    Kjellin, Midori
    Kileng, Hege
    Mor, Orna
    Lennerstrand, Johan
    Fourati, Slim
    Di Maio, Velia Chiara
    Chulanov, Vladimir
    Pawlotsky, Jean-Michel
    Harrigan, P. Richard
    Ceccherini-Silberstein, Francesca
    Garcia, Federico
    JHEP REPORTS, 2022, 4 (05)
  • [35] Direct-acting antivirals for hepatitis C virus-infected patients with hepatocellular carcinoma
    Kazuto Tajiri
    Hiroyuki Ito
    Kengo Kawai
    Yoshiro Kashii
    Yuka Hayashi
    Aiko Murayama
    Masami Minemura
    Terumi Takahara
    Yukihiro Shimizu
    Ichiro Yasuda
    World Journal of Hepatology, 2022, 14 (06) : 1190 - 1199
  • [36] Profile of prescription direct acting antivirals for hepatitis C virus in patients coinfected with HIV/HCV
    Moron Romero, Rocio
    del Carmen Gonzalez, Maria
    Garcia, Cristina
    Moreno, Patricia
    Casas, Inmaculada
    Cabeza, Jose
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2017, 39 (01) : 329 - 330
  • [37] Reactivation of hepatitis B in patients of chronic hepatitis C with hepatitis B virus infection treated with direct acting antivirals
    Yeh, Ming-Lun
    Huang, Chung-Feng
    Hsieh, Meng-Hsuan
    Ko, Yu-Min
    Chen, Kuan-Yu
    Liu, Ta-Wei
    Lin, Yi-Hung
    Liang, Po-Cheng
    Hsieh, Ming-Yen
    Lin, Zu-Yau
    Chen, Shinn-Cherng
    Huang, Ching-I
    Huang, Jee-Fu
    Kuo, Po-Lin
    Dai, Chia-Yen
    Yu, Ming-Lung
    Chuang, Wan-Long
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2017, 32 (10) : 1754 - 1762
  • [38] Direct Acting Antivirals in Hepatitis C Virus Genotype 3 and Advanced Cirrhosis
    Singh, Virendra
    Kumari, Sunita
    Verma, Nipun
    Kumar, Pramod
    De, Arka
    HEPATOLOGY, 2017, 66 : 829A - 829A
  • [39] Hepatitis C Virus-associated Cryoglobulinemic Livedo Reticularis Improved with Direct-acting Antivirals
    Yokoyama, Keiji
    Kino, Tomohiro
    Nagata, Takahiro
    Miyayama, Takashi
    Shibata, Kumiko
    Fukuda, Hiromi
    Yamauchi, Ryo
    Fukunaga, Atsushi
    Umeda, Kaoru
    Takata, Kazuhide
    Tanaka, Takashi
    Shakado, Satoshi
    Sakisaka, Shotaro
    Imafuku, Shinichi
    Hirai, Fumihito
    INTERNAL MEDICINE, 2023, 62 (24) : 3631 - 3636
  • [40] Hepatitis C virus vaccines in the era of new direct-acting antivirals
    Shi, Chao
    Ploss, Alexander
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2013, 7 (02) : 171 - 185
12345